相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 CD51/ITGAV 抗体 (阿比妥珠单抗),生物类似药,科研用途 [ CAS: 1105038-73-0]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Humanized
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
CD51/ITGAV
- 抗体名:
CD51/ITGAV
- 规格:
1mg
产品概览
英文名称:BioSIM anti-Human CD51/ITGAV Antibody (Abituzumab Biosimilar), Research Grade
中文名称:BioSIM 抗人 CD51/ITGAV 抗体 (阿比妥珠单抗),生物类似药,科研用途 [ CAS: 1105038-73-0 ]
供应商:InvivoCrown
产品货号:SIM0738-1mg
产品规格:1mg
核心基础信息
产品属性
- 产品类型:二抗
- 来源宿主:Humanized(人源化)
- 反应性:Human(仅识别人源CD51/ITGAV抗原)
- CAS号:1105038-73-0
研发背景与生产工艺
本产品为阿比妥珠单抗的生物类似药,针对人CD51/ITGAV抗原的重组抗体,生产遵循科研级生物制品工艺要求:
- 生产环境:无动物成分的洁净生产设施
- 细胞培养:体外无蛋白细胞培养技术,减少外源性蛋白干扰
- 纯化流程:多步骤纯化工艺,包含Protein A或G亲和色谱步骤,保障抗体纯度
研究领域与应用场景
聚焦研究领域
- 晚期恶性实体瘤
- 骨转移癌
- 去势抵抗性前列腺癌
适用实验类型
- ELISA(酶联免疫吸附实验)
- FACS(荧光激活细胞分选)
- Functional assay(细胞功能验证实验)
- Research in vivo(体内研究)
免疫原与说明书指引
本产品的免疫原详细信息请参考随附的产品说明书,实验操作需结合说明书中的具体指南进行优化。
规格与包装说明
货号:SIM0738-1mg
规格:1mg/支(包装形式、储存条件及有效期请以产品说明书为准)
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

Product Overview
English Name: BioSIM anti-Human CD51/ITGAV Antibody (Abituzumab Biosimilar), Research Grade
Chinese Name: BioSIM Anti-Human CD51/ITGAV Antibody (Abituzumab), Biosimilar, for Research Use [ CAS: 1105038-73-0 ]
Supplier: InvivoCrown
Product No.: SIM0738-1mg
Product Specification: 1mg
Core Basic Information
Product Attributes
- Product Type: Secondary Antibody
- Source Host: Humanized
- Reactivity: Human (Specifically recognizes human CD51/ITGAV antigen only)
- CAS No.: 1105038-73-0
Research Background and Production Process
This product is a biosimilar of Abituzumab, a recombinant antibody against human CD51/ITGAV antigen, and its production follows the process requirements of research-grade biological products:
- Production Environment: Clean production facilities without animal components
- Cell Culture: Protein-free cell culture technology in vitro to reduce exogenous protein interference
- Purification Process: Multistep purification process, including Protein A or G affinity chromatography steps to ensure antibody purity
Research Fields and Application Scenarios
Focused Research Fields
- Advanced Malignant Solid Tumors
- Bone Metastatic Cancer
- Castration-Resistant Prostate Cancer
Suitable Experimental Types
- ELISA (Enzyme-Linked Immunosorbent Assay)
- FACS (Fluorescence-Activated Cell Sorting)
- Functional assay (Cell Function Verification Experiment)
- Research in vivo (In Vivo Research)
Immunogen and Instruction Manual Guide
For detailed information about the immunogen of this product, please refer to the accompanying product manual. Experimental operations need to be optimized in combination with the specific guidelines in the manual.
Specification and Packaging Instructions
Product No.: SIM0738-1mg
Specification: 1mg per vial (Packaging form, storage conditions, and validity period shall be subject to the product manual)
Note: The above information may change due to product optimization and upgrading. For specific information, please consult Yakeyin Company.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验淋巴瘤, 香菇多糖加化疗治疗晚期胃癌及应用扶正中药和放射治疗子宫颈癌和乳腺癌等。 (6) 靶向治疗加化疗 靶向治疗配合化疗被认为是近年来一大突破。例如针对肿瘤细胞核内her-2基因过度表达而研制的单克隆抗体曲妥珠单抗,在一定程度上可以提高肿瘤细胞对抗肿瘤药的敏感性,从而提高有效率。而且进入了乳腺癌的早期辅助治疗使有Her2过度表达的高危病人复发率明显下降。大肠癌、淋巴瘤、肾癌和肺癌的靶向治疗都取得良好结果。 2、考虑细胞增殖动力学 多年来对于肿瘤细胞增殖动力学的知识
技术资料暂无技术资料 索取技术资料






